Menu Search
Equities

Neurotech International Ltd

NTI:ASX

Neurotech International Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.06
  • Today's Change-0.003 / -4.76%
  • Shares traded1.98m
  • 1 Year change-20.00%
  • Beta2.1336
Data delayed at least 20 minutes, as of Sep 20 2024 06:31 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Neurotech International Ltd grew revenues 165.98% from 1.25m to 3.34m while net income improved from a loss of 7.79m to a smaller loss of 5.07m.
Gross margin100.00%
Net profit margin-151.98%
Operating margin-151.98%
Return on assets-57.86%
Return on equity-63.92%
Return on investment-63.92%
More ▼

Cash flow in AUDView more

In 2024, Neurotech International Ltd increased its cash reserves by 131.32%, or 6.60m. Cash Flow from Financing totalled 11.19m or 335.63% of revenues. In addition the company used 4.60m for operations while cash used for investing totalled .
Cash flow per share-0.0056
Price/Cash flow per share--
Book value per share0.0117
Tangible book value per share0.0117
More ▼

Balance sheet in AUDView more

Neurotech International Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio38.81
Quick ratio38.81
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.